DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
Kids Who Need Sickle Cell Meds Don’t Always Get Them
Less than a fifth of U.S. children with sickle cell anemia are getting the antibiotics that could save their lives, a new study finds.
“Longstanding recommendations say children with sickle cell anemia should take antibiotics daily for their first five years of life,” the study’s lead author, Sarah Reeves, said in a news release from Michigan Medicine.
These antibiotics can protect the children against potentially deadly infections, Reeves said. She’s an epidemiologist with the Child Health Evaluation and Research Center at the University of Michigan Medical School.
Bacterial infections are a major health threat for children with sickle cell anemia, but taking daily antibiotics can reduce that risk by 84 percent, according to the study.
However, the researchers found that just 18 percent of children with the blood disorder were taking antibiotics daily.
Related Content
-
education & researchSickle Cell Disease – Hydroxyurea: What You Need to KnowIf you have sickle cell disease, your bo...
-
education & researchHydroxyurea for Sickle Cell Disease TreatmentHydroxyurea is a medicine used to reduce...
-
news & eventsStep toward gene therapy for sickle cell diseaseA team of researchers at the Stanford Un...
-
news & events1st Patients to Get CRISPR Gene-Editing Treatment Continue to ThriveThe last thing a lot of people want to d...
-
news & eventsLab-Grown Blood: What Is It, and How Could It Be Useful?Sometimes a person may have a blood diso...
-
news & eventsSickle Cell Disease Association of America, Inc. and Hemanext® Inc. Form New Strategic PartnershipSickle Cell Disease Association of Ameri...
-
news & eventsBluebird bio acquires Durham, NC, manufacturing site for lentiviral vector productionbluebird bio said today it has acquired ...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.